Neil H. Bander

Publications

• A Prospective Pilot Study of (89)zr-j591/prostate Specific Membrane Antigen Positron Emission Tomography in Men with Localized Prostate Cancer Undergoing Radical Prostatectomy
  The Journal of Urology. May, 2014  |   Pubmed ID: 24135437
• Circulating Tumor Cells from Prostate Cancer Patients Interact with E-selectin Under Physiologic Blood Flow
  PloS One. 2013  |   Pubmed ID: 24386459
• Prostate-specific Membrane Antigen Expression in Tumor-associated Vasculature of Breast Cancers
  APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica. Dec, 2013  |   Pubmed ID: 24304465
• Bone Marrow Recovery and Subsequent Chemotherapy Following Radiolabeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 in Men with Metastatic Castration-resistant Prostate Cancer
  Frontiers in Oncology. 2013  |   Pubmed ID: 23986881
• Characterization of a Hybrid Dielectrophoresis and Immunocapture Microfluidic System for Cancer Cell Capture
  Electrophoresis. Nov, 2013  |   Pubmed ID: 23925921
• Antibody-drug Conjugate Target Selection: Critical Factors
  Methods in Molecular Biology (Clifton, N.J.). 2013  |   Pubmed ID: 23913139
• Enrichment of Prostate Cancer Cells from Blood Cells with a Hybrid Dielectrophoresis and Immunocapture Microfluidic System
  Biomedical Microdevices. Dec, 2013  |   Pubmed ID: 23807279
• Phase II Study of Lutetium-177-labeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 for Metastatic Castration-resistant Prostate Cancer
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Sep, 2013  |   Pubmed ID: 23714732
• Synergistic Cytotoxicity of Irinotecan and Cisplatin in Dual-drug Targeted Polymeric Nanoparticles
  Nanomedicine (London, England). May, 2013  |   Pubmed ID: 23075285
• Androgen Receptor Signaling in Circulating Tumor Cells As a Marker of Hormonally Responsive Prostate Cancer
  Cancer Discovery. Nov, 2012  |   Pubmed ID: 23093251
• Antibody-drug Conjugate Technology Development for Hematologic Disorders
  Clinical Advances in Hematology & Oncology : H&O. Aug, 2012  |   Pubmed ID: 23072775
• Functional Characterization of Circulating Tumor Cells with a Prostate-cancer-specific Microfluidic Device
  PloS One. 2012  |   Pubmed ID: 22558290
• Preclinical Development and Clinical Translation of a PSMA-targeted Docetaxel Nanoparticle with a Differentiated Pharmacological Profile
  Science Translational Medicine. Apr, 2012  |   Pubmed ID: 22491949
• High Expression of Prostate-specific Membrane Antigen in the Tumor-associated Neo-vasculature is Associated with Worse Prognosis in Squamous Cell Carcinoma of the Oral Cavity
  Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc. Aug, 2012  |   Pubmed ID: 22460809
• Immunocapture of Prostate Cancer Cells by Use of Anti-PSMA Antibodies in Microdevices
  Biomedical Microdevices. Apr, 2012  |   Pubmed ID: 22143878
• Prostate-specific Membrane Antigen As a Potential Novel Vascular Target for Treatment of Glioblastoma Multiforme
  Archives of Pathology & Laboratory Medicine. Nov, 2011  |   Pubmed ID: 22032578
• Targeting the Internal Epitope of Prostate-specific Membrane Antigen with 89Zr-7E11 Immuno-PET
  Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Oct, 2011  |   Pubmed ID: 21908391
• Taxane-induced Blockade to Nuclear Accumulation of the Androgen Receptor Predicts Clinical Responses in Metastatic Prostate Cancer
  Cancer Research. Sep, 2011  |   Pubmed ID: 21799031
• Targeted, Activatable, in Vivo Fluorescence Imaging of Prostate-specific Membrane Antigen (PSMA) Positive Tumors Using the Quenched Humanized J591 Antibody-indocyanine Green (ICG) Conjugate
  Bioconjugate Chemistry. Aug, 2011  |   Pubmed ID: 21740058
• Noninvasive Measurement of Androgen Receptor Signaling with a Positron-emitting Radiopharmaceutical That Targets Prostate-specific Membrane Antigen
  Proceedings of the National Academy of Sciences of the United States of America. Jun, 2011  |   Pubmed ID: 21606347
• 89Zr-DFO-J591 for ImmunoPET of Prostate-specific Membrane Antigen Expression in Vivo
  Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Aug, 2010  |   Pubmed ID: 20660376
• Saporin Toxin-conjugated Monoclonal Antibody Targeting Prostate-specific Membrane Antigen Has Potent Anticancer Activity
  The Prostate. Sep, 2010  |   Pubmed ID: 20623630
• ChemoRad Nanoparticles: a Novel Multifunctional Nanoparticle Platform for Targeted Delivery of Concurrent Chemoradiation
  Nanomedicine (London, England). Apr, 2010  |   Pubmed ID: 20394530
• Anti-prostate-specific Membrane Antigen-based Radioimmunotherapy for Prostate Cancer
  Cancer. Feb, 2010  |   Pubmed ID: 20127956
• Capture of Circulating Tumor Cells from Whole Blood of Prostate Cancer Patients Using Geometrically Enhanced Differential Immunocapture (GEDI) and a Prostate-specific Antibody
  Lab on a Chip. Jan, 2010  |   Pubmed ID: 20024046
• Prostate-specific Membrane Antigen Expression in the Neovasculature of Gastric and Colorectal Cancers
  Human Pathology. Dec, 2009  |   Pubmed ID: 19716160
• Editorial Comment
  The Journal of Urology. Sep, 2009  |   Pubmed ID: 19616227
• Docetaxel Down-regulates the Expression of Androgen Receptor and Prostate-specific Antigen but Not Prostate-specific Membrane Antigen in Prostate Cancer Cell Lines: Implications for PSA Surrogacy
  The Prostate. Oct, 2009  |   Pubmed ID: 19575420
• Superparamagnetic Iron Oxide Nanoparticle-aptamer Bioconjugates for Combined Prostate Cancer Imaging and Therapy
  ChemMedChem. Sep, 2008  |   Pubmed ID: 18613203
• Interaction of Prostate Specific Membrane Antigen with Clathrin and the Adaptor Protein Complex-2
  International Journal of Oncology. Nov, 2007  |   Pubmed ID: 17912448
• Active and Passive Immunotherapy: Vaccines and Antibodies
  BJU International. May, 2007  |   Pubmed ID: 17441928
• Vascular Targeted Therapy with Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 in Advanced Solid Tumors
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Feb, 2007  |   Pubmed ID: 17290063
• Clinical Utility of Radiolabeled Monoclonal Antibodies in Prostate Cancer
  Clinical Genitourinary Cancer. Mar, 2006  |   Pubmed ID: 16729907
• Technology Insight: Monoclonal Antibody Imaging of Prostate Cancer
  Nature Clinical Practice. Urology. Apr, 2006  |   Pubmed ID: 16607370
• Antibody-based Therapeutics: Focus on Prostate Cancer
  Cancer Metastasis Reviews. Dec, 2005  |   Pubmed ID: 16408160
• Radioimmunotherapy of Prostate Cancer Using 90Y- and 177Lu-labeled J591 Monoclonal Antibodies: Effect of Multiple Treatments on Myelotoxicity
  Clinical Cancer Research : an Official Journal of the American Association for Cancer Research. Oct, 2005  |   Pubmed ID: 16203821
• N-glycosylation and Microtubule Integrity Are Involved in Apical Targeting of Prostate-specific Membrane Antigen: Implications for Immunotherapy
  Molecular Cancer Therapeutics. May, 2005  |   Pubmed ID: 15897234
• Prediction of Myelotoxicity Based on Bone Marrow Radiation-absorbed Dose: Radioimmunotherapy Studies Using 90Y- and 177Lu-labeled J591 Antibodies Specific for Prostate-specific Membrane Antigen
  Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. May, 2005  |   Pubmed ID: 15872360
• Phase I Trial of 177lutetium-labeled J591, a Monoclonal Antibody to Prostate-specific Membrane Antigen, in Patients with Androgen-independent Prostate Cancer
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2005  |   Pubmed ID: 15837970
• Pharmacokinetics and Biodistribution of 111In- and 177Lu-labeled J591 Antibody Specific for Prostate-specific Membrane Antigen: Prediction of 90Y-J591 Radiation Dosimetry Based on 111In or 177Lu?
  Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Apr, 2005  |   Pubmed ID: 15809486
• Synthesis and in Vitro Testing of J591 Antibody-dendrimer Conjugates for Targeted Prostate Cancer Therapy
  Bioconjugate Chemistry. Nov-Dec, 2004  |   Pubmed ID: 15546182
• Phase I Trial of Yttrium-90-labeled Anti-prostate-specific Membrane Antigen Monoclonal Antibody J591 for Androgen-independent Prostate Cancer
  Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology. Jul, 2004  |   Pubmed ID: 15173215
• Radioimmunotherapy of Prostate Cancer in Human Xenografts Using Monoclonal Antibodies Specific to Prostate Specific Membrane Antigen (PSMA): Studies in Nude Mice
  The Prostate. Feb, 2004  |   Pubmed ID: 14716739
• Clinical Use of Monoclonal Antibody HuJ591 Therapy: Targeting Prostate Specific Membrane Antigen
  The Journal of Urology. Dec, 2003  |   Pubmed ID: 14610416
• Targeted Systemic Therapy of Prostate Cancer with a Monoclonal Antibody to Prostate-specific Membrane Antigen
  Seminars in Oncology. Oct, 2003  |   Pubmed ID: 14571414
• Targeting Metastatic Prostate Cancer with Radiolabeled Monoclonal Antibody J591 to the Extracellular Domain of Prostate Specific Membrane Antigen
  The Journal of Urology. Nov, 2003  |   Pubmed ID: 14532761
• A Novel Cytoplasmic Tail MXXXL Motif Mediates the Internalization of Prostate-specific Membrane Antigen
  Molecular Biology of the Cell. Dec, 2003  |   Pubmed ID: 14528023
• Prostate-specific Membrane Antigen Association with Filamin A Modulates Its Internalization and NAALADase Activity
  Cancer Research. May, 2003  |   Pubmed ID: 12750292
• Radiolabeled Monoclonal Antibodies Specific to the Extracellular Domain of Prostate-specific Membrane Antigen: Preclinical Studies in Nude Mice Bearing LNCaP Human Prostate Tumor
  Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine. Apr, 2003  |   Pubmed ID: 12679407
• Polarity of Prostate Specific Membrane Antigen, Prostate Stem Cell Antigen, and Prostate Specific Antigen in Prostate Tissue and in a Cultured Epithelial Cell Line
  The Prostate. Apr, 2003  |   Pubmed ID: 12640656